ArticleThe Journal of physiology2026
Maternal protein restriction programs the ageing kidney: Proteomic signatures of early-life origin renal and metabolic dysfunction.
Article in The Journal of physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The ageing kidney remembers its nutritional beginnings.The Journal of physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
The Developmental Origins of Health and Disease framework proposes that adverse exposures during critical developmental windows induce epigenetic programming, increasing lifelong risk of metabolic and organ dysfunction. Maternal protein restriction (MPR) is a well-established model of early-life nutritional stress, associated with reduced nephron number early in life, in addition to renal dysfunction and hypertension during adult life. However, its long-term impact on renal ageing remains unclear. This study investigated the effects of gestational and lactational severe MPR (6% compared to 17% in controls) on the renal proteome of aged male Sprague-Dawley rats (postnatal day 540) using integrated histological, molecular and in silico approaches. MPR induced persistent renal impairment, evidenced by increased serum creatinine and tubular congestion. Proteomic analysis revealed upregulation of proteins related to small-molecule transport, stress response and energy metabolism, particularly within mitochondrial and redox pathways. By contrast, downregulated pathways involved cytoskeletal organization, vesicular transport, immune processes and post-transcriptional regulation, suggesting disruption of endomembrane dynamics. Pathway enrichment highlighted central metabolic networks, including glycolysis, pyruvate metabolism and the tricarboxylic acid cycle. Network and microRNA analyses indicated epigenetic regulation, whereas disease enrichment linked findings to metabolic and renal disorders. Nephron-segment mapping revealed region-specific alterations. Overall, MPR induces persistent renal programming, disrupting metabolism and function and increasing susceptibility to renal and metabolic diseases with ageing. KEY POINTS: Maternal protein restriction (MPR) shifts renal proteome to mitochondrial/redox metabolism. MPR causes renal histopathological lesions during ageing. The impacts of MPR are reflected in cellular and molecular alterations indicative of potential renal dysfunction. Nephron-specific and epigenetic alterations indicate targeted functional disruption. Persistent changes link early malnutrition to renal and metabolic disease risk.
Indexed as
Identifiers
42672919What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.